GERN - Geron $16.01 *** Stem Cell Research! ***
Geron (NASDAQ:GERN) is a biopharmaceutical company focused on
discovering, developing and commercializing therapeutic and
diagnostic products for applications in oncology and regenerative
medicine, and research tools for drug discovery. Geron's product
development programs are based upon patented core technologies:
telomerase, human embryonic stem cells and nuclear transfer.
Stem cell research has been in the news lately and Geron is one
of the companies involved in the reports. Geron financed much of
the work of University of Wisconsin researcher James Thomson, who
first isolated human embryonic stem cells, which many scientists
believe can be used to cure Alzheimer's and Parkinson's disease,
spinal cord injuries and other disorders. Geron has licensing
rights to six types of cells that can be made from those original
lines but there is a dispute over whether the company can add
cell types to its license agreement. Geron's rights to six cell
types is also important because President Bush has said federal
funding will be permitted for research only on cell lines that
are already in existence. Shares of the biotechnology company
rallied recently amid optimism rivals will have to pay it a fee
to develop certain cell types that could be used to treat a range
of diseases. Research this one carefully before initiating any
new positions!
SEP 15.00 GQD IC LB=1.60 OI=685 CB=14.41 DE=20 TY=6.2%
R - Ryder System $22.59 *** Upgrade Into Rally Mode! ***
Ryder System (NYSE:R) operates in three business segments, Fleet
Management Solutions, Supply Chain Solutions and Dedicated Contract Carriage. Fleet Management Solutions provides full-service leasing,
commercial rental and programmed maintenance of trucks, tractors
and trailers to customers, principally in the U.S., Canada and the
United Kingdom. Supply Chain Solutions provides comprehensive
supply chain consulting and lead logistics management solutions
that support customers' entire supply chains, from in-bound raw
materials through distribution of finished goods throughout North
America, in Latin America, Europe and Asia. Dedicated Contract
Carriage provides vehicles and drivers as part of a dedicated
transportation solution, principally in North America. Ryder
Systems exploded out of its short-term base in August after
Morgan Stanley Dean Witter boosted its rating on the Miami-based
trucking company. Analyst James Valentine upgraded the shares to
"outperform" from "neutral," set a price target of $25 on the
stock, and raised his earnings estimates for the company. We
simply favor the technical strength of Ryder Systems, which
suggests further upside potential. Can a "break-out" above the
long-term base be far behind?
SEP 22.50 R IX LB=0.65 OI=93 CB=21.94 DE=20 TY=3.9%
